Key result
Clopidogrel was deemed safe and effective for prehospital STEMI management based on a review of 14 articles and 8 guidelines, though its favorability over newer agents is debated.
Why the study?
Prehospital treatment regimens for STEMI vary across ambulance services, creating a need to evaluate the pharmacological efficacy and safety of clopidogrel and determine whether it should be standard practice.
Does oral clopidogrel improve efficacy and safety in patients with STEMI when administered in the prehospital setting?
Does oral clopidogrel improve efficacy and safety in patients with STEMI when administered in the prehospital setting?
This literature review supports the safety and efficacy of oral clopidogrel for prehospital STEMI management, while noting ongoing debate regarding its use versus newer agents like ticagrelor and prasugrel.
Answers are grounded in this paper and cite their sources.
Supports prehospital clopidogrel in STEMI; leaves open comparative efficacy versus newer agents in prospective trials.
Introduction: Clopidogrel is an anticoagulant commonly used in the prehospital environment for the management of ST-elevation myocardial infarction (STEMI). Some ambulance services have incorporated this into their treatment regimens; however, others hold a variety of alternative pharmacological interventions. Aims: The purpose of this study is to examine and determine the pharmacological efficacy and safety of clopidogrel in the management of patients with STEMI and assess whether ambulance services should use the drug as part of standard practice. Methods: A literature review was conducted to identify articles relating to the administration of clopidogrel in the prehospital setting. Fourteen peer-reviewed journal articles and eight clinical practice guidelines from international ambulance services were included in this review. Results: According to this literature review, clopidogrel has been deemed safe, effective and practical for widespread use in the prehospital environment for the management of STEMI. However, some disagreement has arisen over whether clopidogrel is a more favourable anticoagulant than ticagrelor and prasugrel. Conclusion: Anticoagulants such as clopidogrel should be strongly considered as a standard treatment regimen in the prehospital management of STEMI across international jurisdictions.
No takes yet. Share an insight, caveat, or question.
Sealy et al. (2021) conducted a review in ST-elevation myocardial infarction (STEMI). Clopidogrel was evaluated. Clopidogrel was deemed safe and effective for prehospital STEMI management based on a review of 14 articles and 8 guidelines, though its favorability over newer agents is debated.
Synapse has enriched 10 related papers. Consider them for comparative context: